Medtronic hires Ishrak as chairman, CEO from GE

Justine Varieur Cadet | | Cardiovascular Business | Cardiac Imaging
Medtronic's board of directors has named Omar Ishrak as the company’s new chairman and CEO, effective June 13.

Ishrak formerly served as president and CEO of GE Healthcare Systems, a $12 billion division of GE Healthcare, which has approximately 20,000 employees in 120 countries. Ishrak was also a senior vice president of GE and a member of the GE's corporate executive council.

Prior to joining GE Healthcare in 1995 and working in the clinical systems division and the ultrasounds units, Ishrak spent more than 13 years in senior technology development and business management roles at Philips Ultrasound, Diasonics and Elbit Ultrasound Group. 

Ishrak succeeds William A. Hawkins, who in December 2010 announced his intention to retire from the company.

 

Justine Varieur Cadet

Related Content

Cardiologists work to standardize the diagnosis and management of acute myocarditis
New AI program delivers rapid, accurate echo video assessments
Cardiologists to highlight the many benefits of AI-powered CCTA evaluations
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Cleerly’s momentum continues as AI specialists raise $106M
Philips, Mayo Clinic using AI to improve cardiac MRI technology

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.